Structure

Physi-Chem Properties

Molecular Weight:  262.08
Volume:  261.72
LogP:  2.297
LogD:  1.431
LogS:  -2.526
# Rotatable Bonds:  2
TPSA:  97.99
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.621
Synthetic Accessibility Score:  2.722
Fsp3:  0.214
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.003
MDCK Permeability:  6.043607299943687e-06
Pgp-inhibitor:  0.006
Pgp-substrate:  0.735
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.878
30% Bioavailability (F30%):  0.626

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.01
Plasma Protein Binding (PPB):  97.7361068725586%
Volume Distribution (VD):  0.407
Pgp-substrate:  4.483479022979736%

ADMET: Metabolism

CYP1A2-inhibitor:  0.804
CYP1A2-substrate:  0.935
CYP2C19-inhibitor:  0.04
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.437
CYP2C9-substrate:  0.835
CYP2D6-inhibitor:  0.268
CYP2D6-substrate:  0.311
CYP3A4-inhibitor:  0.074
CYP3A4-substrate:  0.163

ADMET: Excretion

Clearance (CL):  13.483
Half-life (T1/2):  0.93

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.113
Drug-inuced Liver Injury (DILI):  0.831
AMES Toxicity:  0.721
Rat Oral Acute Toxicity:  0.079
Maximum Recommended Daily Dose:  0.083
Skin Sensitization:  0.928
Carcinogencity:  0.066
Eye Corrosion:  0.04
Eye Irritation:  0.924
Respiratory Toxicity:  0.068

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472046

Natural Product ID:  NPC472046
Common Name*:   Karuquinone A
IUPAC Name:   5,8-dihydroxy-6-methyl-7-(2-oxopropyl)-2,3-dihydronaphthalene-1,4-dione
Synonyms:  
Standard InCHIKey:  ZQIYBGRIURFSLB-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C14H14O5/c1-6(15)5-8-7(2)13(18)11-9(16)3-4-10(17)12(11)14(8)19/h18-19H,3-5H2,1-2H3
SMILES:  CC(=O)Cc1c(O)c2C(=O)CCC(=O)c2c(c1C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3334765
PubChem CID:   86275690
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000023] Naphthalenes
        • [CHEMONTID:0000153] Naphthoquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7122 Fusarium solani Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[21348469]
NPO7122 Fusarium solani Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[25163667]
NPO7122 Fusarium solani Species Nectriaceae Eukaryota n.a. n.a. n.a. PMID[28257197]
NPO7122 Fusarium solani Species Nectriaceae Eukaryota n.a. n.a. n.a. Database[Article]
NPO7122 Fusarium solani Species Nectriaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens IC50 = 4000.0 nM PMID[522223]
NPT737 Cell Line HUVEC Homo sapiens IC50 = 1800.0 nM PMID[522223]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 1100.0 nM PMID[522223]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 1900.0 nM PMID[522223]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472046 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9333 High Similarity NPC472047
0.8952 High Similarity NPC278928
0.8889 High Similarity NPC88864
0.881 High Similarity NPC205992
0.876 High Similarity NPC155211
0.871 High Similarity NPC306765
0.871 High Similarity NPC1991
0.871 High Similarity NPC96915
0.8699 High Similarity NPC68756
0.8699 High Similarity NPC142956
0.8699 High Similarity NPC152525
0.8689 High Similarity NPC307174
0.8672 High Similarity NPC193169
0.864 High Similarity NPC471530
0.8583 High Similarity NPC199253
0.8583 High Similarity NPC198305
0.8583 High Similarity NPC136588
0.8583 High Similarity NPC55949
0.8571 High Similarity NPC282923
0.8561 High Similarity NPC143438
0.856 High Similarity NPC160499
0.8548 High Similarity NPC310540
0.8527 High Similarity NPC225051
0.8527 High Similarity NPC52407
0.8512 High Similarity NPC232178
0.8504 High Similarity NPC146647
0.8504 High Similarity NPC34414
0.848 Intermediate Similarity NPC131799
0.8473 Intermediate Similarity NPC474311
0.8473 Intermediate Similarity NPC474813
0.8473 Intermediate Similarity NPC272268
0.8473 Intermediate Similarity NPC472308
0.8468 Intermediate Similarity NPC375356
0.8462 Intermediate Similarity NPC50924
0.845 Intermediate Similarity NPC70622
0.8443 Intermediate Similarity NPC285829
0.8443 Intermediate Similarity NPC206778
0.8438 Intermediate Similarity NPC31799
0.8438 Intermediate Similarity NPC31539
0.8425 Intermediate Similarity NPC48248
0.8413 Intermediate Similarity NPC227741
0.8413 Intermediate Similarity NPC295202
0.8413 Intermediate Similarity NPC3224
0.8413 Intermediate Similarity NPC231774
0.8413 Intermediate Similarity NPC136342
0.8413 Intermediate Similarity NPC49647
0.8409 Intermediate Similarity NPC305060
0.8409 Intermediate Similarity NPC245923
0.84 Intermediate Similarity NPC234890
0.84 Intermediate Similarity NPC173978
0.84 Intermediate Similarity NPC74507
0.8397 Intermediate Similarity NPC14377
0.8397 Intermediate Similarity NPC258502
0.8397 Intermediate Similarity NPC80035
0.8387 Intermediate Similarity NPC300274
0.8372 Intermediate Similarity NPC17083
0.8372 Intermediate Similarity NPC85342
0.8359 Intermediate Similarity NPC99731
0.8333 Intermediate Similarity NPC254847
0.8333 Intermediate Similarity NPC103540
0.8321 Intermediate Similarity NPC288089
0.8308 Intermediate Similarity NPC58685
0.8308 Intermediate Similarity NPC309430
0.8308 Intermediate Similarity NPC242358
0.8308 Intermediate Similarity NPC110609
0.8308 Intermediate Similarity NPC246693
0.8296 Intermediate Similarity NPC92079
0.8281 Intermediate Similarity NPC237225
0.8271 Intermediate Similarity NPC53414
0.8271 Intermediate Similarity NPC471905
0.8271 Intermediate Similarity NPC147418
0.8271 Intermediate Similarity NPC53206
0.8258 Intermediate Similarity NPC161632
0.8254 Intermediate Similarity NPC199273
0.8244 Intermediate Similarity NPC114183
0.8244 Intermediate Similarity NPC267205
0.8244 Intermediate Similarity NPC53896
0.8244 Intermediate Similarity NPC115458
0.8244 Intermediate Similarity NPC314048
0.8244 Intermediate Similarity NPC254603
0.8244 Intermediate Similarity NPC171968
0.824 Intermediate Similarity NPC282577
0.8231 Intermediate Similarity NPC244699
0.8209 Intermediate Similarity NPC61398
0.8209 Intermediate Similarity NPC4214
0.8209 Intermediate Similarity NPC416
0.8209 Intermediate Similarity NPC123714
0.8209 Intermediate Similarity NPC13715
0.8195 Intermediate Similarity NPC315275
0.8195 Intermediate Similarity NPC86524
0.8188 Intermediate Similarity NPC471683
0.8182 Intermediate Similarity NPC161304
0.8182 Intermediate Similarity NPC240163
0.8182 Intermediate Similarity NPC12070
0.8182 Intermediate Similarity NPC270899
0.8175 Intermediate Similarity NPC143898
0.8175 Intermediate Similarity NPC275145
0.8162 Intermediate Similarity NPC283292
0.8162 Intermediate Similarity NPC124365
0.8162 Intermediate Similarity NPC187843
0.8154 Intermediate Similarity NPC117609
0.8154 Intermediate Similarity NPC475741
0.8154 Intermediate Similarity NPC108129
0.8148 Intermediate Similarity NPC242994
0.8148 Intermediate Similarity NPC26924
0.8148 Intermediate Similarity NPC138099
0.8148 Intermediate Similarity NPC190457
0.8145 Intermediate Similarity NPC216297
0.8145 Intermediate Similarity NPC7151
0.8145 Intermediate Similarity NPC473662
0.8134 Intermediate Similarity NPC471452
0.8125 Intermediate Similarity NPC254492
0.8125 Intermediate Similarity NPC51037
0.812 Intermediate Similarity NPC281513
0.812 Intermediate Similarity NPC283088
0.812 Intermediate Similarity NPC249272
0.812 Intermediate Similarity NPC22222
0.8116 Intermediate Similarity NPC475813
0.8115 Intermediate Similarity NPC108288
0.8115 Intermediate Similarity NPC477453
0.811 Intermediate Similarity NPC12818
0.811 Intermediate Similarity NPC236189
0.8106 Intermediate Similarity NPC294226
0.8095 Intermediate Similarity NPC91478
0.8092 Intermediate Similarity NPC41847
0.8092 Intermediate Similarity NPC93015
0.8088 Intermediate Similarity NPC315578
0.8088 Intermediate Similarity NPC181560
0.8088 Intermediate Similarity NPC169452
0.808 Intermediate Similarity NPC190971
0.8074 Intermediate Similarity NPC206207
0.8062 Intermediate Similarity NPC176130
0.8062 Intermediate Similarity NPC84672
0.8062 Intermediate Similarity NPC83572
0.8062 Intermediate Similarity NPC72667
0.8062 Intermediate Similarity NPC78364
0.8062 Intermediate Similarity NPC69424
0.806 Intermediate Similarity NPC191976
0.8049 Intermediate Similarity NPC269414
0.8047 Intermediate Similarity NPC123506
0.8045 Intermediate Similarity NPC202225
0.8045 Intermediate Similarity NPC166480
0.8045 Intermediate Similarity NPC44437
0.8045 Intermediate Similarity NPC282780
0.8043 Intermediate Similarity NPC469885
0.8043 Intermediate Similarity NPC471682
0.8031 Intermediate Similarity NPC273683
0.8031 Intermediate Similarity NPC477153
0.803 Intermediate Similarity NPC477406
0.8029 Intermediate Similarity NPC246638
0.8029 Intermediate Similarity NPC290550
0.8029 Intermediate Similarity NPC305845
0.8029 Intermediate Similarity NPC204045
0.8016 Intermediate Similarity NPC120545
0.8015 Intermediate Similarity NPC114620
0.8015 Intermediate Similarity NPC103337
0.8015 Intermediate Similarity NPC296158
0.8014 Intermediate Similarity NPC112816
0.8 Intermediate Similarity NPC96024
0.8 Intermediate Similarity NPC300540
0.8 Intermediate Similarity NPC53001
0.8 Intermediate Similarity NPC247250
0.8 Intermediate Similarity NPC767
0.7986 Intermediate Similarity NPC244691
0.7986 Intermediate Similarity NPC471906
0.7984 Intermediate Similarity NPC15837
0.7984 Intermediate Similarity NPC41567
0.7971 Intermediate Similarity NPC69755
0.7971 Intermediate Similarity NPC193555
0.7971 Intermediate Similarity NPC257644
0.7971 Intermediate Similarity NPC135524
0.7971 Intermediate Similarity NPC474961
0.7971 Intermediate Similarity NPC19631
0.7971 Intermediate Similarity NPC239136
0.797 Intermediate Similarity NPC48036
0.797 Intermediate Similarity NPC263817
0.797 Intermediate Similarity NPC59459
0.7956 Intermediate Similarity NPC96421
0.7956 Intermediate Similarity NPC183345
0.7955 Intermediate Similarity NPC474517
0.7955 Intermediate Similarity NPC72669
0.7955 Intermediate Similarity NPC471851
0.7941 Intermediate Similarity NPC173980
0.7941 Intermediate Similarity NPC87723
0.7939 Intermediate Similarity NPC303910
0.7939 Intermediate Similarity NPC276238
0.7939 Intermediate Similarity NPC171460
0.7937 Intermediate Similarity NPC229649
0.7926 Intermediate Similarity NPC118919
0.7923 Intermediate Similarity NPC19432
0.7914 Intermediate Similarity NPC66593
0.7914 Intermediate Similarity NPC238629
0.791 Intermediate Similarity NPC287604
0.791 Intermediate Similarity NPC472262
0.791 Intermediate Similarity NPC474519
0.791 Intermediate Similarity NPC475645
0.791 Intermediate Similarity NPC161964
0.7902 Intermediate Similarity NPC294646
0.7902 Intermediate Similarity NPC315520
0.7899 Intermediate Similarity NPC110810

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472046 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8333 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD1470 Approved
0.816 Intermediate Similarity NPD1201 Approved
0.8115 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD7390 Discontinued
0.7681 Intermediate Similarity NPD2346 Discontinued
0.7482 Intermediate Similarity NPD5404 Approved
0.7482 Intermediate Similarity NPD5408 Approved
0.7482 Intermediate Similarity NPD5406 Approved
0.7482 Intermediate Similarity NPD5405 Approved
0.7466 Intermediate Similarity NPD3226 Approved
0.7431 Intermediate Similarity NPD2534 Approved
0.7431 Intermediate Similarity NPD2533 Approved
0.7431 Intermediate Similarity NPD2532 Approved
0.7431 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD3300 Phase 2
0.7372 Intermediate Similarity NPD943 Approved
0.7364 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD7635 Approved
0.7357 Intermediate Similarity NPD2935 Discontinued
0.7286 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD1164 Approved
0.7203 Intermediate Similarity NPD2800 Approved
0.7165 Intermediate Similarity NPD1398 Phase 1
0.7101 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD2313 Discontinued
0.7063 Intermediate Similarity NPD2344 Approved
0.7051 Intermediate Similarity NPD6232 Discontinued
0.7045 Intermediate Similarity NPD2932 Approved
0.7045 Intermediate Similarity NPD3019 Approved
0.7025 Intermediate Similarity NPD7473 Discontinued
0.7021 Intermediate Similarity NPD1607 Approved
0.7021 Intermediate Similarity NPD6651 Approved
0.7014 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7340 Approved
0.6987 Remote Similarity NPD6959 Discontinued
0.696 Remote Similarity NPD2342 Discontinued
0.6944 Remote Similarity NPD1471 Phase 3
0.6923 Remote Similarity NPD2799 Discontinued
0.6905 Remote Similarity NPD9266 Approved
0.6905 Remote Similarity NPD74 Approved
0.6885 Remote Similarity NPD289 Clinical (unspecified phase)
0.6879 Remote Similarity NPD1240 Approved
0.6871 Remote Similarity NPD2309 Approved
0.687 Remote Similarity NPD9493 Approved
0.6846 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6846 Remote Similarity NPD497 Approved
0.6846 Remote Similarity NPD5951 Approved
0.6835 Remote Similarity NPD5710 Approved
0.6835 Remote Similarity NPD5711 Approved
0.6825 Remote Similarity NPD9264 Approved
0.6825 Remote Similarity NPD9263 Approved
0.6825 Remote Similarity NPD9267 Approved
0.6812 Remote Similarity NPD2798 Approved
0.6806 Remote Similarity NPD1510 Phase 2
0.6806 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6788 Remote Similarity NPD1283 Approved
0.6777 Remote Similarity NPD288 Approved
0.6769 Remote Similarity NPD496 Approved
0.6769 Remote Similarity NPD495 Approved
0.6769 Remote Similarity NPD498 Approved
0.6738 Remote Similarity NPD7985 Registered
0.6716 Remote Similarity NPD1651 Approved
0.671 Remote Similarity NPD2393 Clinical (unspecified phase)
0.671 Remote Similarity NPD2801 Approved
0.671 Remote Similarity NPD7819 Suspended
0.6694 Remote Similarity NPD844 Approved
0.6667 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1511 Approved
0.6647 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6623 Remote Similarity NPD7410 Clinical (unspecified phase)
0.662 Remote Similarity NPD411 Approved
0.662 Remote Similarity NPD3764 Approved
0.6619 Remote Similarity NPD1203 Approved
0.6618 Remote Similarity NPD3023 Approved
0.6618 Remote Similarity NPD3026 Approved
0.6615 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6608 Remote Similarity NPD6212 Phase 3
0.6608 Remote Similarity NPD6213 Phase 3
0.6608 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6607 Remote Similarity NPD8150 Discontinued
0.6599 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6599 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6599 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6597 Remote Similarity NPD447 Suspended
0.6594 Remote Similarity NPD1755 Approved
0.6593 Remote Similarity NPD3025 Approved
0.6593 Remote Similarity NPD3024 Approved
0.6591 Remote Similarity NPD9281 Approved
0.6579 Remote Similarity NPD1512 Approved
0.6577 Remote Similarity NPD7003 Approved
0.657 Remote Similarity NPD6535 Approved
0.657 Remote Similarity NPD6534 Approved
0.6569 Remote Similarity NPD1281 Approved
0.6569 Remote Similarity NPD1611 Approved
0.6567 Remote Similarity NPD7644 Approved
0.6562 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6554 Remote Similarity NPD1549 Phase 2
0.6544 Remote Similarity NPD4626 Approved
0.6544 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6538 Remote Similarity NPD1934 Approved
0.6531 Remote Similarity NPD6099 Approved
0.6531 Remote Similarity NPD6100 Approved
0.6529 Remote Similarity NPD845 Approved
0.6529 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6522 Remote Similarity NPD3972 Approved
0.6522 Remote Similarity NPD9269 Phase 2
0.6522 Remote Similarity NPD9717 Approved
0.6516 Remote Similarity NPD4380 Phase 2
0.6512 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6508 Remote Similarity NPD1929 Approved
0.6508 Remote Similarity NPD9261 Approved
0.6508 Remote Similarity NPD1930 Approved
0.6508 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6506 Remote Similarity NPD5031 Approved
0.6506 Remote Similarity NPD5027 Approved
0.6506 Remote Similarity NPD5029 Approved
0.6471 Remote Similarity NPD9268 Approved
0.6467 Remote Similarity NPD4955 Approved
0.6467 Remote Similarity NPD5034 Approved
0.6467 Remote Similarity NPD5028 Approved
0.6467 Remote Similarity NPD4954 Approved
0.6467 Remote Similarity NPD5026 Approved
0.6467 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6467 Remote Similarity NPD36 Approved
0.6462 Remote Similarity NPD4750 Phase 3
0.6457 Remote Similarity NPD7699 Phase 2
0.6457 Remote Similarity NPD7700 Phase 2
0.6457 Remote Similarity NPD1237 Approved
0.6456 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6452 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6452 Remote Similarity NPD7458 Discontinued
0.6449 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6429 Remote Similarity NPD1876 Approved
0.6429 Remote Similarity NPD6696 Suspended
0.6429 Remote Similarity NPD1932 Approved
0.6424 Remote Similarity NPD5844 Phase 1
0.6423 Remote Similarity NPD1809 Phase 2
0.6419 Remote Similarity NPD1551 Phase 2
0.6418 Remote Similarity NPD3317 Approved
0.6412 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6407 Remote Similarity NPD5030 Phase 2
0.6403 Remote Similarity NPD1608 Approved
0.6403 Remote Similarity NPD4878 Approved
0.64 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6398 Remote Similarity NPD5494 Approved
0.6397 Remote Similarity NPD9545 Approved
0.6384 Remote Similarity NPD6778 Approved
0.6384 Remote Similarity NPD6776 Approved
0.6384 Remote Similarity NPD6779 Approved
0.6384 Remote Similarity NPD6777 Approved
0.6384 Remote Similarity NPD6780 Approved
0.6384 Remote Similarity NPD6782 Approved
0.6384 Remote Similarity NPD6781 Approved
0.6375 Remote Similarity NPD3749 Approved
0.637 Remote Similarity NPD7325 Clinical (unspecified phase)
0.637 Remote Similarity NPD230 Phase 1
0.6358 Remote Similarity NPD3750 Approved
0.6352 Remote Similarity NPD2296 Approved
0.6351 Remote Similarity NPD4308 Phase 3
0.6345 Remote Similarity NPD6663 Approved
0.6331 Remote Similarity NPD8312 Approved
0.6331 Remote Similarity NPD8313 Approved
0.6329 Remote Similarity NPD6844 Discontinued
0.6328 Remote Similarity NPD164 Approved
0.6319 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6316 Remote Similarity NPD5038 Approved
0.6316 Remote Similarity NPD5037 Approved
0.6312 Remote Similarity NPD3882 Suspended
0.6301 Remote Similarity NPD2979 Phase 3
0.6294 Remote Similarity NPD5736 Approved
0.6294 Remote Similarity NPD9494 Approved
0.6289 Remote Similarity NPD1465 Phase 2
0.6278 Remote Similarity NPD7696 Phase 3
0.6278 Remote Similarity NPD7698 Approved
0.6278 Remote Similarity NPD7435 Discontinued
0.6278 Remote Similarity NPD7697 Approved
0.6276 Remote Similarity NPD3268 Approved
0.6273 Remote Similarity NPD7075 Discontinued
0.627 Remote Similarity NPD3020 Approved
0.627 Remote Similarity NPD2066 Phase 3
0.6266 Remote Similarity NPD7411 Suspended
0.626 Remote Similarity NPD2329 Discontinued
0.6259 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6257 Remote Similarity NPD5036 Approved
0.625 Remote Similarity NPD4628 Phase 3
0.625 Remote Similarity NPD6398 Clinical (unspecified phase)
0.625 Remote Similarity NPD8166 Discontinued
0.625 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6243 Remote Similarity NPD7871 Phase 2
0.6243 Remote Similarity NPD7870 Phase 2
0.6243 Remote Similarity NPD6836 Approved
0.6241 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6241 Remote Similarity NPD182 Clinical (unspecified phase)
0.6233 Remote Similarity NPD520 Approved
0.6232 Remote Similarity NPD5691 Approved
0.6228 Remote Similarity NPD6020 Phase 2
0.6218 Remote Similarity NPD920 Approved
0.6212 Remote Similarity NPD3022 Approved
0.6212 Remote Similarity NPD3021 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data